AXON 8-K Current Reports
AXON ENTERPRISE, INC. - 230 current reports
AXON ENTERPRISE, INC. 8-K Report, Shareholder Vote Results (Jun 1, 2026)
Axon Enterprise, Inc. (AXON) held its 2026 Annual Meeting of Shareholders on May 28, 2026, with a strong turnout of approximately 90.5% of outstanding shares represented. The meeting confirmed the election of all nine director nominees for the upcoming year, with each nominee receiving a substantial majority of the votes cast. This indicates continued shareholder confidence in the current board leadership and governance structure. Furthermore, shareholders overwhelmingly approved the "Say-on-Pay" proposal, a non-binding advisory vote on executive compensation, signifying shareholder alignment with the company's compensation practices. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026 was also ratified with near-unanimous support. These outcomes suggest a stable and supportive shareholder base for Axon's operational and strategic direction.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (May 6, 2026)
Axon Enterprise, Inc. (AXON) has filed an 8-K on May 6, 2026, to report its financial results for the first quarter ended March 31, 2026. The filing primarily consists of a shareholder letter (Exhibit 99.1) detailing the company's performance. While specific financial figures are not detailed within the 8-K text itself, investors should refer to the attached shareholder letter for comprehensive insights into revenue, profitability, and any forward-looking statements. This report serves as the official notification of the Q1 2026 results. Investors seeking detailed operational and financial condition updates should carefully review Exhibit 99.1. The company's disclosure emphasizes that this information is furnished and not deemed 'filed' for certain regulatory purposes, which is standard for earnings release disclosures.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Apr 10, 2026)
Axon Enterprise, Inc. (AXON) announced that Matthew McBrady will not be standing for re-election as a director at the upcoming 2026 Annual Meeting of Shareholders. Mr. McBrady will continue to serve until the end of his current term at the meeting. Importantly, his decision is stated to be unrelated to any disagreements with the Company regarding its operations, policies, or practices, which mitigates concerns about internal disputes or governance issues. Investors should note that while Mr. McBrady's departure is a change in board composition, the company has indicated it was his personal decision regarding re-election. The Board expressed gratitude for his service, highlighting his contributions to the company's growth and progress. This announcement does not appear to signal any immediate operational or strategic shifts but represents a transition in the Board's membership.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Mar 11, 2026)
Axon Enterprise, Inc. (AXON) announced that director Julie Anne Cullivan will not stand for re-election at the upcoming 2026 Annual Meeting of Shareholders. Ms. Cullivan's tenure will conclude at the meeting, and her decision is stated to be voluntary, without any disagreements with the Company regarding its operations, policies, or practices. The Board of Directors has expressed gratitude for her significant contributions to the Company's growth and leadership during her service. This announcement, filed on March 11, 2026, relates to a change in the composition of the Board. Investors should note that while Ms. Cullivan's departure is amicable, any changes in board leadership can sometimes signal shifts in strategic focus or governance. However, given the information provided, the impact is primarily a procedural one related to board refreshment.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Feb 24, 2026)
Axon Enterprise, Inc. (AXON) filed an 8-K on February 24, 2026, to report its financial results for the fourth quarter and full fiscal year ended December 31, 2025. The accompanying shareholder letter (Exhibit 99.1) contains the detailed financial performance and outlook. Investors should refer to this exhibit for specific revenue figures, profitability metrics, and any forward-looking statements regarding the company's performance in the upcoming year. The filing is procedural, primarily serving to incorporate the shareholder letter into public record. While the 8-K itself doesn't contain the numerical results, it directs investors to the official shareholder letter for the most crucial financial information. This includes insights into the drivers of revenue growth, any significant cost impacts, and management's commentary on market conditions affecting Axon's business segments, such as TASER, Cloud, and Artificial Intelligence solutions.
AXON ENTERPRISE, INC. 8-K Report, Corporate Update (Feb 13, 2026)
Axon Enterprise, Inc. (AXON) announced in an 8-K filing dated February 13, 2026, the complete redemption and conversion of its 0.50% convertible senior notes due 2027. This action effectively retires all outstanding convertible notes, simplifying the company's capital structure. The company utilized cash for the redemption and also settled a significant portion of the notes through a combination of cash and stock, demonstrating a strategic approach to managing its debt obligations.
AXON ENTERPRISE, INC. 8-K/A Report, Corporate Update (Feb 4, 2026)
Axon Enterprise, Inc. has announced the full redemption of its 0.50% convertible senior notes due 2027, with a redemption date set for February 10, 2026. This action will see the company repurchase all outstanding notes at their principal amount plus accrued interest. Investors holding these notes are provided a limited window to convert them into Axon's common stock before the conversion deadline of February 6, 2026. The company also disclosed a Market Disruption Event on January 29, 2026, which has extended the observation period for calculating the conversion settlement value. This extension means the observation period will now conclude on February 9, 2026, and settlement for converted notes is expected on February 11, 2026. This event will impact the exact amount of cash and stock shareholders will receive upon conversion.
AXON ENTERPRISE, INC. 8-K Report, Corporate Update (Dec 18, 2025)
Axon Enterprise, Inc. has announced its intention to redeem all outstanding 0.50% convertible senior notes due 2027 on February 10, 2026. The redemption price will be 100% of the principal amount plus accrued and unpaid interest. This action signals a proactive approach by Axon to manage its debt obligations, potentially to reduce future interest expenses or optimize its capital structure. Investors holding these notes should be aware of the redemption timeline and their option to convert their notes into Axon common stock before February 6, 2026. The conversion settlement amount will be determined based on a 30-trading day observation period, providing a mechanism for shareholders to benefit from potential stock appreciation prior to conversion. The redemption of these notes is a significant event that could impact the company's balance sheet and future financial flexibility.
AXON ENTERPRISE, INC. 8-K/A Report, Unregistered Securities Sale (Dec 17, 2025)
Axon Enterprise, Inc. (AXON) has filed an 8-K report detailing the closing of privately negotiated exchange transactions involving its 0.50% Convertible Senior Notes due 2027. These transactions allowed certain holders to exchange a significant principal amount of Notes for a combination of cash and Axon's common stock. This exchange effectively reduces the company's outstanding convertible debt and increases its outstanding share count, which are key considerations for investors assessing the company's capital structure and potential dilution.
AXON ENTERPRISE, INC. 8-K Report, Unregistered Securities Sale (Dec 10, 2025)
Axon Enterprise, Inc. (AXON) has announced its entry into privately negotiated Exchange Agreements with certain holders of its 0.50% convertible senior notes due 2027. These agreements will facilitate the exchange of approximately $177.9 million in aggregate principal amount of these notes for a combination of cash and newly issued Axon common stock. The exact number of shares to be issued will be determined based on a one-day volume-weighted average price (VWAP) on December 10, 2025, with an estimated issuance of 468,000 shares assuming a hypothetical VWAP of $550.95. This transaction is expected to reduce the outstanding principal amount of the convertible notes to approximately $100.1 million upon closing, anticipated around December 16, 2025. The company is utilizing an exemption under Section 4(a)(2) of the Securities Act for the issuance of these shares, requiring holders to be accredited and qualified institutional buyers. Investors should note that the unwinding of hedging positions by some noteholders could potentially lead to increased volatility in Axon's stock price around the closing date.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Nov 4, 2025)
Axon Enterprise, Inc. (AXON) filed an 8-K on November 4, 2025, to report its financial results for the quarter ended September 30, 2025, through a shareholder letter. While the 8-K itself doesn't contain detailed financials, it references an attached Exhibit 99.1, which investors should consult for specific performance metrics, revenue figures, and profitability. This filing indicates that the company is providing its quarterly update as per standard disclosure requirements.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Sep 2, 2025)
Axon Enterprise, Inc. announced a strategic addition to its Board of Directors with the appointment of Todd Morgenfeld, effective August 28, 2025. Mr. Morgenfeld brings extensive financial and operational leadership experience, having previously held key executive roles at Pinterest, Inc. and Twitter, Inc., as well as serving as a CFO/COO. His appointment, which increases the Board size to eleven members, signifies the company's ongoing commitment to robust governance and financial oversight. Mr. Morgenfeld's expertise is expected to be a valuable asset as Axon continues its growth trajectory and navigates complex capital markets. Mr. Morgenfeld's compensation package is structured to align with market practices for independent directors, including initial and annual restricted stock units and cash retainers for his committee memberships. These arrangements are consistent with the company's existing director compensation program. The company has also entered into a standard indemnification agreement with Mr. Morgenfeld. His background, including experience at Silver Lake Partners and Goldman Sachs, as well as his service on other public company boards, underscores his suitability for this role and his potential to contribute significantly to Axon's strategic decision-making.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Aug 4, 2025)
Axon Enterprise, Inc. (AXON) filed an 8-K on August 4, 2025, to disclose its financial results for the quarter ended June 30, 2025, via a shareholder letter. While the 8-K itself does not contain detailed financial figures, it serves as an official notification that the company has released its quarterly performance. Investors should refer to the attached Exhibit 99.1, the full shareholder letter, for comprehensive data on revenue, profitability, segment performance, and forward-looking guidance. This filing is crucial for understanding the company's recent operational and financial trajectory.
AXON ENTERPRISE, INC. 8-K Report, Shareholder Vote Results (Jun 2, 2025)
Axon Enterprise, Inc. (AXON) filed an 8-K on June 2, 2025, reporting the results of its 2025 Annual Meeting of Shareholders held on May 29, 2025. A significant majority of outstanding shares, approximately 89.8%, were represented at the meeting, indicating strong shareholder engagement. All director nominees were overwhelmingly elected, reflecting continued confidence in the company's leadership and strategic direction. The advisory vote on executive compensation ('Say-on-Pay') also passed, albeit with a more divided vote compared to the director elections, suggesting that while shareholders generally approve of compensation practices, there is a notable segment expressing dissent. Furthermore, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2025 was ratified with near unanimous support, underscoring shareholder trust in the company's financial oversight.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (May 7, 2025)
Axon Enterprise, Inc. (AXON) has filed an 8-K report on May 7, 2025, primarily addressing a restatement of previously issued financial statements. The company's Audit Committee, in consultation with management, determined that its audited consolidated financial statements for the fiscal year ended December 31, 2024, and unaudited condensed consolidated financial statements for the quarters ended March 31, 2024, and September 30, 2024, should no longer be relied upon due to an error in the balance sheet presentation of its 0.50% convertible senior notes due 2027. The error involved the misclassification of these notes, amounting to $690.0 million, from current liabilities to long-term liabilities on the balance sheet. This reclassification is due to the notes becoming convertible at the option of holders during the applicable subsequent calendar quarters because the company's stock price met certain thresholds. Importantly, Axon states that this reclassification does not impact total assets, total liabilities, equity, or the statements of operations, cash flows, or equity. The company plans to amend its Form 10-K for the fiscal year ended December 31, 2024, to reflect these restated financials.
AXON ENTERPRISE, INC. 8-K/A Report, Unregistered Securities Sale (Mar 14, 2025)
Axon Enterprise, Inc. (AXON) has filed an 8-K report detailing the conclusion of privately negotiated exchange transactions involving its 0.50% Convertible Senior Notes due 2027. The company successfully exchanged approximately $407.5 million in aggregate principal amount of these notes for a combination of cash and newly issued shares of Axon's common stock. This transaction aims to reduce outstanding convertible debt and modify the company's capital structure.
AXON ENTERPRISE, INC. 8-K Report, Material Agreement (Mar 11, 2025)
Axon Enterprise, Inc. (AXON) has announced the successful closing of its private offering of $1,000.0 million in 6.125% senior notes due 2030 and $750.0 million in 6.250% senior notes due 2033. This $1.75 billion in aggregate principal amount of new debt, issued under separate indentures, is intended for general corporate purposes. Potential uses include repurchasing or redeeming existing convertible notes, funding growth initiatives, and supporting strategic acquisitions or investments in new technologies. Concurrently, Axon amended its existing credit agreement, increasing its revolving credit facility by $100 million to $300 million (with an option for further increase) and extending the maturity date to March 11, 2030. These actions strengthen Axon's financial flexibility and capital structure, providing resources for continued expansion and strategic opportunities.
AXON ENTERPRISE, INC. 8-K Report, Unregistered Securities Sale (Mar 7, 2025)
Axon Enterprise, Inc. (AXON) announced on March 7, 2025, a significant transaction involving its 0.50% convertible senior notes due 2027. The company entered into private agreements with certain noteholders to exchange approximately $407.5 million in aggregate principal amount of these notes. The exchange consideration will comprise cash and shares of Axon's common stock. This move is expected to reduce the outstanding principal of these notes to approximately $282.5 million upon closing, anticipated around March 13, 2025. An estimated 1.0 million shares of common stock are expected to be issued in this exchange, based on the closing price of $499.31 on March 6, 2025, and a volume-weighted average price calculation over a specified period. Investors should note that the noteholders who have hedged their equity exposure may unwind these positions, potentially leading to substantial buying activity in Axon's common stock. This could significantly impact the stock's market price, though the exact magnitude and effect are unpredictable. The shares issued will be unregistered, relying on an exemption under Section 4(a)(2) of the Securities Act, as holders are expected to be accredited and qualified institutional buyers.
AXON ENTERPRISE, INC. 8-K Report, Corporate Update (Mar 5, 2025)
Axon Enterprise, Inc. (AXON) announced its intention to offer $1,500.0 million in aggregate principal amount of senior notes, split between 2030 and 2033 maturities. This offering is being conducted as a private placement to qualified institutional buyers and non-U.S. persons, exempt from standard registration requirements. The proceeds from this note offering are expected to be utilized in conjunction with an amendment to the company's existing credit agreement. In parallel with the note offering, Axon plans to amend its credit agreement to enhance its financial flexibility. Key changes include an increase in the revolving credit facility by $100.0 million to $300.0 million, with an option for a further $100.0 million increase. The availability for letters of credit will also rise by $20.0 million to $50.0 million. Additionally, the maturity date of the credit agreement will be extended to five years from the Amendment's closing date, subject to certain conditions related to outstanding convertible notes. These actions suggest proactive capital management and a strategic approach to funding future growth and operational needs.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Feb 25, 2025)
Axon Enterprise, Inc. (AXON) has filed an 8-K report on February 25, 2025, to disclose its financial results for the fourth quarter and full fiscal year ended December 31, 2024. This filing primarily references a shareholder letter (Exhibit 99.1) which contains the detailed financial performance data. Investors should refer to this attached letter for a comprehensive understanding of the company's revenue, profitability, and any forward-looking statements or strategic updates provided by management for the period. The significance of this 8-K lies in its role as the official vehicle for disseminating Axon's latest financial performance. While the 8-K itself is brief, it directs stakeholders to the shareholder letter for critical insights into the company's operational and financial health. This includes an overview of the company's performance against expectations, potential growth drivers, and any challenges or opportunities anticipated by Axon's leadership.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Nov 7, 2024)
Axon Enterprise, Inc. (AXON) has filed an 8-K report on November 7, 2024, to announce its third-quarter financial results for the period ending September 30, 2024. The filing includes a shareholder letter detailing these results, accompanied by comprehensive financial statements, segment reporting, balance sheets, cash flow information, and statistical measures. Notably, the report provides reconciliations between GAAP and non-GAAP financial measures, offering investors a clearer view of the company's operational performance beyond standard accounting principles. This report is crucial for understanding Axon's recent financial trajectory and operational highlights.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Aug 6, 2024)
Axon Enterprise, Inc. (AXON) has filed an 8-K on August 6, 2024, to announce its second quarter financial results for the period ended June 30, 2024. The filing primarily incorporates by reference a shareholder letter containing detailed financial performance information, including statements of operations, balance sheets, cash flow, segment reporting, statistical measures, and reconciliations of GAAP to non-GAAP financial measures. Investors should refer to the attached Exhibit 99.1 for the full suite of financial data and management's commentary on the quarter's performance. While this 8-K serves as notification of the earnings release, the detailed operational and financial insights, including specific revenue figures, profitability metrics, and forward-looking statements, are contained within the accompanying shareholder letter. This letter will be crucial for understanding Axon's current financial health, growth drivers, and any significant developments that may impact future performance. Investors are encouraged to review Exhibit 99.1 thoroughly for a comprehensive understanding of Axon's Q2 2024 results.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (May 13, 2024)
Axon Enterprise, Inc. (AXON) filed an 8-K on May 13, 2024, detailing the outcomes of its 2024 Annual Meeting of Shareholders held on May 10, 2024. The primary focus of the filing is the shareholder approval of amendments to key equity incentive plans, including the Amended and Restated 2022 Stock Incentive Plan, the 2024 eXponential Stock Plan (2024 Employee XSP), and a specific CEO Performance Award for Patrick W. Smith. These approvals are crucial for the company's ability to grant future equity-based compensation to its employees and officers, ensuring continued alignment of interests and talent retention.
AXON ENTERPRISE, INC. 8-K Report, Material Agreement (May 13, 2024)
Axon Enterprise, Inc. has filed an 8-K report detailing the establishment of a new "at the market" equity offering program. This program allows Axon to sell up to 1,954,450 shares of its common stock, which were unsold from a previous offering that expired on April 20, 2024. The shares will be sold through J.P. Morgan Securities LLC as the agent, with Axon retaining the discretion to determine the timing and amounts of any sales. The company intends to use the net proceeds for general corporate purposes, including funding tax obligations related to stock compensation, supporting growth initiatives, and potential acquisitions. This filing indicates Axon's strategy to potentially raise capital through the sale of existing registered shares. Investors should note that the company is not obligated to sell any shares and can suspend or terminate the program at any time. The agreement with the agent includes a commission of up to 2% on gross sales. The overall capacity for this offering is modest relative to Axon's market capitalization, suggesting it's a flexible tool for opportunistic capital raising rather than a significant financing event.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (May 6, 2024)
Axon Enterprise, Inc. (AXON) has filed an 8-K on May 6, 2024, to report its financial results for the first quarter ended March 31, 2024, via a shareholder letter. The filing incorporates by reference a detailed shareholder letter, including audited consolidated statements of operations, segment reporting, balance sheets, cash flow information, statistical measures, and GAAP to non-GAAP reconciliations, attached as Exhibit 99.1. Investors should refer to Exhibit 99.1 for the comprehensive financial performance details of the first quarter. While this 8-K filing primarily serves to present these results, it does not contain new operational updates or strategic disclosures beyond what is provided in the shareholder letter. The information is furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Mar 5, 2024)
Axon Enterprise, Inc. (AXON) filed a Form 8-K on March 5, 2024, primarily to announce a change in its Board of Directors. Dr. Mark W. Kroll has resigned from the Board, with his resignation effective as of the Company's 2024 Annual Meeting of Shareholders. The company expressed gratitude for his contributions to its growth and progress during his tenure. This filing does not indicate any immediate operational or financial changes. Investors should note that board composition changes, while important for governance, do not typically signal a shift in the company's strategic direction or financial performance unless accompanied by other information. The company's statement thanks Dr. Kroll for his deep commitment and leadership, suggesting a respectful and amicable departure. Investors should monitor future filings for any potential updates regarding board appointments or strategic shifts.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Feb 27, 2024)
Axon Enterprise, Inc. filed an 8-K on February 27, 2024, primarily to announce financial results for the fourth quarter and fiscal year ended December 31, 2023, through a shareholder letter. While the specific financial figures are detailed in an attached exhibit, this filing signals that Axon is providing an update on its performance. Investors should refer to the shareholder letter for comprehensive details on revenue, profitability, and any forward-looking statements regarding the company's outlook. The filing also includes a significant change in the company's independent auditor, appointing PricewaterhouseCoopers LLP effective after the upcoming 10-K filing, and dismissing Grant Thornton LLP after a long tenure. The change in auditors is a noteworthy event for investors, indicating a potential shift in audit approach or oversight. The report explicitly states that the decision to switch auditors was made by the Audit Committee and that there were no disagreements with Grant Thornton leading to their dismissal, though a material weakness in internal controls was noted related to revenue recognition. Investors should monitor future financial reports for any impact of the new auditor on financial reporting and internal control remediation efforts.
AXON ENTERPRISE, INC. 8-K Report, Exhibit Filing (Dec 21, 2023)
Axon Enterprise, Inc. (AXON) filed an 8-K on December 21, 2023, to report amendments to its corporate bylaws, effective immediately as of December 20, 2023. These changes, stemming from a periodic review of governance documents, introduce significant updates primarily affecting stockholder rights and meeting procedures. The most notable addition is the implementation of "Proxy Access Provisions," allowing a qualifying group of stockholders to nominate directors and include them in the company's proxy materials, subject to specific ownership thresholds and holding periods. Further amendments clarify the timelines for stockholder nominations and proposals, incorporate requirements related to universal proxy cards as mandated by the SEC, and refine the information disclosure needed from stockholders making nominations. The company has also updated its bylaws concerning proxy card colors, meeting adjournments, and has established exclusive forum selection clauses for disputes, designating Delaware Chancery Court for certain state law matters and U.S. federal district courts for Securities Act of 1933 claims. Investors should note these changes as they impact corporate governance and shareholder engagement processes.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Dec 14, 2023)
Axon Enterprise, Inc. (AXON) has filed an 8-K report detailing significant changes to its Chief Executive Officer's (CEO) compensation and employment terms, effective December 8, 2023. The company has entered into a new Employment Agreement with CEO Patrick W. Smith, outlining his continued leadership through December 31, 2030, with provisions for at-will employment thereafter. Notably, the agreement sets Mr. Smith's base salary at minimum wage, with no increases until 2031, and he will not be eligible for annual bonuses or equity awards during this period, except for a substantial one-time grant. This filing also addresses a previously granted stock option award and a subsequent letter agreement. The company has waived a holding period on shares valued at approximately $25 million, allowing Mr. Smith to contribute them to a charitable fund. Investors should note the specific financial commitments required from Mr. Smith under both agreements if he terminates his employment under certain conditions. The new employment terms, particularly the unusual compensation structure for the CEO, suggest a strategic focus on retaining and incentivizing other key employees.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Nov 7, 2023)
Axon Enterprise, Inc. (AXON) filed an 8-K on November 7, 2023, primarily to report its third-quarter 2023 financial results via a shareholder letter. This filing provides investors with an update on the company's operational and financial performance for the period. The details of these results, including financial statements and reconciliations, are furnished as an exhibit to this report, allowing stakeholders to assess Axon's recent business trajectory.
AXON ENTERPRISE, INC. 8-K/A Report, Executive Changes (Sep 8, 2023)
This Form 8-K/A filing from Axon Enterprise, Inc. (AXON) serves as an amendment to a prior report, primarily to disclose updated compensation arrangements for two key executives, Joshua M. Isner (President) and Brittany Bagley (Chief Operating Officer and Chief Financial Officer), following their recent promotions. The Compensation Committee of the Board of Directors approved these revisions, aiming to align executive pay with market benchmarks, generally around the 50th percentile of peer data. Key adjustments include revised base salaries and annual target cash incentive compensation for Mr. Isner, along with significant grants of restricted stock units (RSUs) for both executives. These RSU grants are designed to incentivize long-term performance and retention, with vesting schedules extending over several years. Investors should note these compensation adjustments reflect the expanded responsibilities of these critical leadership roles and the company's strategy to reward and retain top talent.
AXON ENTERPRISE, INC. 8-K/A Report, Shareholder Vote Results (Aug 30, 2023)
This 8-K/A filing from Axon Enterprise, Inc. (AXON) serves as an amendment to a previous report, specifically to clarify the frequency of shareholder advisory votes on executive compensation. The Board of Directors has officially determined that these "say-on-pay" advisory votes will be held annually, aligning with the outcome of shareholder Proposal No. 3 from the May 31, 2023 Annual Meeting. This decision directly responds to shareholder input and formalizes the annual advisory vote on executive compensation. Investors should note that this filing does not introduce new financial information or material business updates; its sole purpose is to communicate the Board's decision regarding the frequency of this specific shareholder vote, demonstrating responsiveness to shareholder sentiment on executive pay.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Aug 8, 2023)
This 8-K filing from Axon Enterprise, Inc. (AXON), dated August 8, 2023, announces the release of the company's second quarter 2023 financial results via a shareholder letter. While the 8-K itself is brief, it directs investors to Exhibit 99.1 for detailed financial performance, including statements of operations, segment reporting, balance sheets, cash flow information, statistical measures, and reconciliations of GAAP to non-GAAP financial measures. Investors should consult this attached exhibit for a comprehensive understanding of Axon's performance during the second quarter.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Jul 5, 2023)
Axon Enterprise, Inc. (AXON) announced significant leadership changes via an 8-K filing on July 5, 2023, detailing events from June 28, 2023. The company promoted Joshua M. Isner to President, a role where he will continue to focus on execution, growth, and global expansion, reporting to CEO Rick Smith. Isner's extensive experience within Axon, including his prior role as COO and Chief Revenue Officer, positions him to drive top-line performance and explore new markets and product categories. Furthermore, Brittany Bagley has been appointed as Chief Operating Officer and Chief Financial Officer. Bagley, who joined Axon in September 2022 as CFO, will now be responsible for integrating financial functions with operations, including manufacturing and supply chain, aiming for enhanced operational efficiency and financial strength. Her background as CFO of Sonos and experience at KKR and Goldman Sachs brings valuable financial and operational expertise to this expanded role. Both appointments are effective immediately, with no immediate changes to their compensation, though a review is pending.
AXON ENTERPRISE, INC. 8-K Report, Shareholder Vote Results (Jun 2, 2023)
This 8-K filing from Axon Enterprise, Inc. details the outcomes of its Annual Meeting of Shareholders held on May 31, 2023. A significant majority of outstanding shares were represented, indicating strong shareholder engagement. Key to investors, all incumbent directors were overwhelmingly re-elected, and the advisory "Say-on-Pay" proposal regarding executive compensation received substantial support, as did the ratification of Grant Thornton LLP as the company's independent auditor for fiscal year 2023. Notably, the company elected not to submit Proposal No. 5, concerning a "2023 CEO Performance Award," to a vote, citing that withdrawal was in the best interest of the company. Furthermore, a shareholder proposal to discontinue the development of a non-lethal TASER drone system was decisively defeated, signaling continued shareholder confidence in the company's strategic direction and product development. In summary, the meeting reflects robust shareholder support for the board of directors, executive compensation practices, auditor appointment, and the company's overall business strategy, including its product development initiatives. The withdrawal of the CEO performance award proposal and the rejection of the shareholder proposal on drone development are important signals regarding internal decision-making and shareholder sentiment on strategic matters.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (May 9, 2023)
Axon Enterprise, Inc. (AXON) filed an 8-K on May 9, 2023, to announce its first-quarter 2023 financial results. The report primarily serves as a vehicle to furnish a shareholder letter detailing these results, along with accompanying unaudited financial statements and reconciliations. Investors should refer to the attached Exhibit 99.1 for the comprehensive details of the company's performance and financial condition for the period ended March 31, 2023. While this 8-K filing itself does not contain the specific financial figures, it directs investors to the detailed shareholder letter and financial statements where such information is disclosed. Key metrics, operational performance, and forward-looking statements, if any, would be found within the provided exhibits, offering insights into Axon's business trajectory and its financial health.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Mar 15, 2023)
Axon Enterprise, Inc. (AXON) announced on March 15, 2023, a significant expansion of its Board of Directors with the appointment of three new members: Erika Ayers, Graham Smith, and Jeri Williams. These appointments, effective March 16, 2023 (for Mr. Smith and Ms. Williams) and June 1, 2023 (for Ms. Ayers), aim to bring diverse expertise to the company's governance. The new directors' compensation is aligned with existing board compensation practices, including restricted stock unit awards and annual cash compensation. The addition of these individuals brings a wealth of experience in technology, finance, executive leadership, and public safety. Erika Ayers has a strong background in transforming and growing media and digital organizations. Graham Smith brings extensive experience as a CFO and board member in the enterprise software sector, including leadership roles at Splunk and Salesforce. Jeri Williams offers a unique perspective from her tenure as Chief of Police for the Phoenix Police Department and her leadership in law enforcement organizations. These appointments are expected to enhance Axon's strategic direction and oversight as the company continues its growth trajectory.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Feb 28, 2023)
Axon Enterprise, Inc. (AXON) filed an 8-K on February 28, 2023, to announce its fourth quarter and full-year 2022 financial results via a shareholder letter. The filing primarily serves to incorporate by reference the detailed financial information, which includes unaudited condensed consolidated statements of operations, segment reporting, balance sheets, cash flow information, statistical measures, and GAAP to non-GAAP reconciliations. This 8-K does not introduce new operational developments but rather provides investors with the official release of the company's performance for the period ending December 31, 2022. Investors should refer to Exhibit 99.1 attached to this filing for the comprehensive financial data. This exhibit is critical for understanding Axon's revenue, profitability, and financial position as reported for Q4 and the full fiscal year 2022. While the 8-K itself is a procedural filing, the underlying financial results disclosed in the shareholder letter are of paramount importance for evaluating the company's recent performance and its trajectory.
AXON ENTERPRISE, INC. 8-K Report, Material Agreement (Dec 19, 2022)
Axon Enterprise, Inc. (AXON) announced on December 19, 2022, the execution of a new Credit Agreement, effective December 15, 2022. This agreement establishes a senior unsecured multi-currency revolving credit facility with a principal amount of up to $200 million, which includes an option to increase it to $300 million at the company's request and lender approval. The facility is designed to provide flexibility for general corporate purposes, including working capital needs and strategic acquisitions. The Credit Agreement has a maturity date of December 15, 2027, with certain conditions tied to the maturity of their convertible senior notes. The interest rates on borrowings will be floating, based on various benchmark rates like SOFR, EURIBOR, TIBOR, or RFR, plus an applicable margin determined by Axon's net leverage ratio. The company will also pay a commitment fee on the unused portion of the facility. Covenants include financial reporting, limitations on debt and liens, and a requirement to maintain a maximum net leverage ratio of 3.50:1.00 and a minimum interest coverage ratio of 3.50:1.00.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Dec 14, 2022)
Axon Enterprise, Inc. (AXON) filed an 8-K on December 14, 2022, to report a key leadership transition. Luke S. Larson, the Company's President, will be returning from medical leave and moving from his role as President to a strategic advisor position, effective December 31, 2022. This change follows his medical leave announced in May 2022, during which Joshua M. Isner was promoted to Chief Operating Officer. Mr. Larson's new role as strategic advisor will focus on advising the company on its growth initiatives, leveraging his significant contributions to the company's software and sensor business. This move suggests a planned succession and continued strategic involvement from a key executive, even as the company navigates leadership changes. Investors can interpret this as a sign of stability and continued focus on growth strategies.
AXON ENTERPRISE, INC. 8-K Report, Material Agreement (Dec 9, 2022)
Axon Enterprise, Inc. (AXON) has filed an 8-K detailing a significant financing transaction involving the issuance of $690 million in aggregate principal amount of 0.50% Convertible Senior Notes due 2027. The notes were sold to qualified institutional buyers and carry a low annual interest rate, with a conversion price of approximately $228.73 per share. This issuance aims to strengthen the company's financial position and provide flexibility for future growth. In conjunction with the note offering, Axon entered into convertible note hedge transactions costing $70.7 million and sold warrants generating $124.3 million. The hedge transactions are designed to mitigate potential dilution from the convertible notes, while the warrants, with a higher strike price of $338.86, could be dilutive if exercised. These hedging and warrant transactions are separate from the notes and are intended to manage the financial implications of the convertible debt issuance.
AXON ENTERPRISE, INC. 8-K Report, Corporate Update (Dec 7, 2022)
Axon Enterprise, Inc. (AXON) announced on December 6, 2022, the pricing of an upsized private offering of $600 million aggregate principal amount of 0.50% convertible senior notes due 2027. This offering, sold to qualified institutional buyers, was increased from an initial announcement of $500 million, indicating strong investor demand. The company also secured an option for purchasers to acquire an additional $90 million of notes. In conjunction with the notes offering, Axon entered into convertible note hedge and warrant transactions. These financial instruments are designed to mitigate the dilutive impact of the convertible notes and manage the company's exposure to interest rate fluctuations. This strategic move aims to strengthen Axon's financial position and provide flexibility for future growth initiatives.
AXON ENTERPRISE, INC. 8-K Report, Corporate Update (Dec 5, 2022)
Axon Enterprise, Inc. (AXON) announced on December 5, 2022, its intention to launch a private offering of $500 million in aggregate principal amount of convertible senior notes due 2027. The company also has the option to issue an additional $75 million in notes. This offering, subject to market conditions, aims to raise capital and is being conducted under Rule 144A for qualified institutional buyers. In conjunction with the notes offering, Axon plans to enter into convertible note hedge and warrant transactions to mitigate potential dilution. Furthermore, the company has secured a waiver for its existing revolving credit facility and intends to establish a new unsecured revolving credit facility of up to $200 million, with an option to increase it to $300 million. This strategic financial maneuver suggests proactive management of its capital structure to support ongoing operations and potential future growth, while also updating its risk factors regarding evolving regulatory landscapes.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Nov 8, 2022)
Axon Enterprise, Inc. (AXON) filed an 8-K on November 8, 2022, to report its financial results for the third quarter of 2022. The filing primarily consists of a shareholder letter and accompanying financial statements, which were released on the same date. This report provides investors with key updates on the company's operational performance and financial condition for the period ending September 30, 2022. While the 8-K itself is brief, it directs readers to Exhibit 99.1 for comprehensive details. This exhibit contains the unaudited condensed consolidated statements of operations, segment reporting, balance sheets, cash flow information, statistical measures, and reconciliations of GAAP to non-GAAP financial measures. Investors should refer to Exhibit 99.1 for a deep dive into Axon's Q3 2022 performance, including revenue, profitability, and cash flow metrics.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Aug 10, 2022)
Axon Enterprise, Inc. (AXON) announced a significant leadership change in their finance department via an 8-K filing on August 10, 2022. The company has appointed Brittany Bagley as its new Chief Financial Officer (CFO) and Chief Business Officer, effective September 26, 2022. Ms. Bagley will also assume the role of Principal Financial and Accounting Officer, succeeding the interim CFO, James C. Zito, who will remain with the company as Senior Vice President of Accounting. This appointment brings a seasoned executive with extensive experience in finance and investment to Axon's leadership team.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (Aug 9, 2022)
Axon Enterprise, Inc. (AXON) filed an 8-K on August 9, 2022, to report its financial results for the second quarter of 2022 via a shareholder letter. While the 8-K itself is brief, it references an attached Exhibit 99.1 containing detailed financial information, including operating results, segment reporting, balance sheets, cash flow, and non-GAAP reconciliations. Investors should refer to Exhibit 99.1 for the full financial performance details of the quarter. The primary purpose of this filing is to publicly disseminate the company's Q2 2022 financial performance. The inclusion of both GAAP and non-GAAP measures provides a comprehensive view, allowing investors to assess operational effectiveness and profitability under different accounting standards. The timing of this report indicates it is providing timely updates to the market following the close of the second fiscal quarter.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (Jun 2, 2022)
This 8-K filing from Axon Enterprise, Inc. announces a significant change in its executive leadership. Effective immediately, Joshua M. Isner has been promoted to Chief Operating Officer. This promotion comes as President Luke S. Larson begins a medical leave of absence. Mr. Isner, previously the Chief Revenue Officer, will assume Mr. Larson's responsibilities, leveraging his extensive experience in driving global growth and sales operations since joining Axon in 2009. The filing also details the compensation package for James C. Zito, who is serving as Interim Chief Financial Officer. Mr. Zito will receive a base salary of $550,000 for 2022, with additional cash compensation of $300,000 specifically for his interim CFO role. His equity awards include $650,000 in restricted stock units and $200,000 in performance stock units, with a portion of the PSU value attributed to his interim position.
AXON ENTERPRISE, INC. 8-K Report, Shareholder Vote Results (May 20, 2022)
This 8-K filing from Axon Enterprise, Inc. (AXON) on May 20, 2022, reports the outcomes of its Annual Meeting of Shareholders held on the same date. A significant majority of outstanding shares were represented, indicating strong shareholder engagement. The most impactful resolution for investors was the approval to declassify the Board of Directors, which transitions the company to annual elections for all board members, potentially increasing director accountability and responsiveness to shareholder interests. Additionally, the filing confirms the election of Class A directors and the ratification of Grant Thornton LLP as the independent registered public accounting firm. Shareholder approval was also granted for the 2022 Stock Incentive Plan, which is crucial for long-term executive and employee retention and alignment with shareholder value creation. The advisory vote on executive compensation ('Say-on-Pay') also received majority support, signaling general shareholder agreement with the company's compensation practices.
AXON ENTERPRISE, INC. 8-K Report, Financial Results (May 10, 2022)
Axon Enterprise, Inc. (AXON) filed an 8-K on May 10, 2022, to report its first quarter 2022 financial results via a shareholder letter. While the filing itself is brief, it incorporates detailed financial information as an exhibit. Investors should refer to the attached Exhibit 99.1 for comprehensive data on the company's performance, including statements of operations, segment reporting, balance sheets, and cash flow. The filing also includes reconciliations of GAAP to non-GAAP financial measures, which are crucial for understanding the company's operational profitability and underlying trends beyond standard accounting metrics. The primary purpose of this 8-K is to provide timely disclosure of Axon's Q1 2022 financial performance. Investors can expect to find discussions on revenue, profitability, and any significant operational developments that impacted the quarter's results. The inclusion of segment reporting is particularly important for understanding the performance drivers across Axon's various business units, such as TASER, Axon Cloud, and Axon Body 3.
AXON ENTERPRISE, INC. 8-K Report, Executive Changes (May 4, 2022)
Axon Enterprise, Inc. (AXON) announced a leadership change in its finance department via an 8-K filing on May 4, 2022. The company's Chief Financial Officer (CFO), Jawad A. Ahsan, has resigned, effective immediately, to pursue other opportunities. The company has commenced a search for a permanent CFO and Mr. Ahsan will assist in the transition process. In light of this departure, Axon has appointed Jim Zito as the interim CFO. Mr. Zito, who has been with Axon since 2017 and currently holds the position of Senior Vice President of Accounting and corporate controller, brings extensive experience from his previous roles at GE Healthcare and PricewaterhouseCoopers LLP. The filing also notes that Axon has raised its 2022 revenue outlook and reaffirmed its long-term revenue growth targets, details of which are provided in an accompanying press release.